Companies / Cytosorbents Corp

Cytosorbents Corp

Nasdaq: CTSOCIK 1175151PRINCETON, NJ

Financials · FY2018

Revenue$22.50M
Net income$-8.20M
Total debt$17.24M
Cash$4.41M
Diluted EPS$-0.13
Shares outstanding62.8M

Ownership

62.8M shares outstanding · as of Jul 31, 2026
3.8%Insiders
Ownership
Insiders3.79%2,382,545
10%+ / strategic8.32%5,230,099
Institutions18.28%11,489,371
Public float69.60%43,740,733

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 2

View all →
Insider% of sharesShares
Chan Phillip P.CEOChief Executive Officer · Director
2.78%1,744,432
Mariani Peter JChief Financial Officer
1.02%638,113

Institutional holders 52

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Skylands Capital, LLC
13F manager
TrimCommon Stock$-83.3K-147K
-7.93%
1,707,498
2.72% of shares
low
Q1 2026
as of
Geode Capital Management, LLC
13F manager
AddCommon Stock$58.6K+103K
+17.14%
707,262
1.13% of shares
low
Q2 2026
as of
BlackRock, Inc.
13F manager
TrimCommon Stock$-53.6K-143K
-18.60%
627,211
1.00% of shares
low
Q3 2023
as of
Barclays PLC
13F manager
NewCommon Stock$10.5K+6K
5,577
<0.01% of shares
low
Q4 2023
as of
Barclays PLC
13F manager
ExitCommon Stock$-10.5K-6K
-100.00%
low
Q2 2026
as of
LPL Financial LLC
13F manager
AddCommon Stock$10.1K+27K
+117.29%
50,119
0.08% of shares
low
Q4 2025
as of
First National Bank of Omaha
13F manager
NewCommon Stock$9.8K+15K
15,225
0.02% of shares
low
Q1 2026
as of
Avenir Corp
13F manager
TrimCommon Stock$-8.1K-14K
-0.27%
5,215,776
8.30% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Avenir CorpPassive13G/A5,230,099

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CTSOCommon StockEquity23283X206BBG000C3P8V0